Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives

Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological cancers. Despite improvements in medical treatments, the prognosis for EOC remains poor, and there is an urgent need for new therapeutic strategies. Immune checkpoint inhibitors (CPIs) have dramatically improved surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Borella, Fulvio, Ghisoni, Eleonora, Giannone, Gaia, Cosma, Stefano, Benedetto, Chiara, Valabrega, Giorgio, Katsaros, Dionyssios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151145/
https://www.ncbi.nlm.nih.gov/pubmed/32156035
http://dx.doi.org/10.3390/diagnostics10030146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151145/
https://www.ncbi.nlm.nih.gov/pubmed/32156035
http://dx.doi.org/10.3390/diagnostics10030146

Ejemplares similares